Clinical Trials in Ohio

Showing 7381-7400 of 15,929 trials

Blepharospasm Patient Survey for Patients With Blepharospasm

NCT01686061

The purpose of this survey is to collect detailed information on patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA, including how often they are treated with botulinum toxin, how long their treatment lasts, how satisfied they are with their treatment, and if there is any improvement in their symptoms with the treatment.

Blepharospasm

Merz Pharmaceuticals GmbH124 participantsStarted Sep 2012

Fountain Valley, California, United States • Sarasota, Florida, United States • Boston, Massachusetts, United States +2 more locations

Active Not RecruitingPhase 1/232 miles

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

NCT03294083

This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety/efficacy evaluation trial of Pexa-Vec plus Cemiplimab in patients with metastatic or unresectable renal cell carcinoma (RCC). The trial consists of a dose-escalation stage, where the maximum feasible dose of Pexa-Vec in combination with Cemiplimab will be determined, followed by an expansion stage. During the expansion patients will receive Cemiplimab alone or in combination with Pexa-Vec, which will be administered either through intravenous (IV) or intratumoral (IT) injection.

Renal Cell Carcinoma

SillaJen, Inc.89 participantsStarted Jun 2018

Irvine, California, United States • Miami, Florida, United States • St Louis, Missouri, United States +15 more locations

Blepharospasm Patient Survey for Patients With Blepharospasm

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

Find Trials by Condition in Ohio

Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

Treatments Against RA and Effect on FDG-PET/CT

Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

P3 (Prepared, Protected, emPowered)

Safety and Efficacy of Sofwave Treatment to Lift Lax Skin

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

MyLeukoMAP™ Genomic Survival Prediction Assay Pivotal Clinical Study

A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD